A review of the current treatment of renal artery stenosis.
OBJECTIVE
Atherosclerotic renal artery stenosis (ARAS) is associated with morbidity and mortality consequent to progressive ischemic renal failure and the cardiovascular consequences of hypertension. There is considerable uncertainty concerning the optimal management of patients with this condition. This review considers the aetiological factors and the physiologic consequences of ARAS and compares the results of clinical studies of medical and endovascular therapies on blood pressure control and preservation of renal function.


RESULTS
Although, in patients with fibromuscular disease the results of percutaneous transluminal angioplasty (PTA) are clearly superior to medical therapy and surgery, in asymptomatic patients with ARAS the antihypertensive benefits and preservation of renal function of endovascular, surgical and medical therapies appear similar. In selected symptomatic patients interventions may, however, be life-saving. Surgery is generally reserved for arterial occlusions with preserved renal parenchyma and function.


CONCLUSIONS
The results of larger, multicentre, randomised, controlled trials are required to clearly clarify the role of interventional therapy in asymptomatic patients.
Mwipatayi
B P
BP
Department of Vascular Surgery, Royal Perth Hospital, Perth, WA, Australia. bibombe@iinet.net.au
Beningfield
S J
SJ
White
L E
LE
Irish
A
A
Abbas
M
M
Sieunarine
K
K
D000465:Algorithms; D006801:Humans; D012078:Renal Artery Obstruction / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D015607:Stents; D014656:Vascular Surgical Procedures